AVTX
#2476
Avalo Therapeutics, Inc. - Common Stock
18.9 1 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.56%
Monthly Change
+25.98%
6 month change
+16.66%
Year Change
+285.13%
Previous Close
19.2 1
Open
18.9 1
Low
18.9 1
High
18.9 1
Volume
67
Financials
- Market Capitalization 994.01 M
- Employee 33
- Founded 2011
- CEO N/A
- Website www.avalotx.com
- Headquarter Delaware, United States
- FIGI BBG001QHW0Y8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.11
Price to sales ratio
4 125.96
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2444 |  OLMA Olema Pharmaceuticals, Inc. - Common Stock | 11.85 USD | -0.50% | -8.49% | +19.82% | +44.69% | 1.04 B USD | ||
| 2457 |  SANA Sana Biotechnology, Inc. - Common Stock | 3.64 USD | -5.45% | -8.54% | +32.36% | -13.74% | 1.01 B USD | ||
| 2482 |  JANX Janux Therapeutics, Inc. - Common Stock | 16.14 USD | -1.59% | +3.00% | +17.90% | -39.44% | 984.29 M USD | ||
| 2484 |  ANRO Alto Neuroscience, Inc. Common Stock | 28.03 USD | +5.93% | +5.34% | +30.25% | +930.51% | 983.68 M USD |
Frequently asked questions about Avalo Therapeutics, Inc. - Common Stock
What is the Avalo Therapeutics, Inc. - Common Stock stock price today?
The current price of Avalo Therapeutics, Inc. - Common Stock (AVTX) is 18.91. Over the past 24 hours, the stock has changed by -1.56%. Follow the AVTX chart for real-time price dynamics.
What is the stock ticker of Avalo Therapeutics, Inc. - Common Stock?
Avalo Therapeutics, Inc. - Common Stock trades under the ticker AVTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Avalo Therapeutics, Inc. - Common Stock stock going up?
AVTX has changed by -7.30% over the last week, +25.98% over the last month, and +285.13% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Avalo Therapeutics, Inc. - Common Stock net income for the last quarter?
Avalo Therapeutics, Inc. - Common Stock reported net income of -19.63 M for the last quarter. The previous quarter showed -13.72 M, which means net income changed by -43.08%.
How many employees does Avalo Therapeutics, Inc. - Common Stock have?
As of the latest available data, Avalo Therapeutics, Inc. - Common Stock has 33 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Avalo Therapeutics, Inc. - Common Stock stock?
You can buy Avalo Therapeutics, Inc. - Common Stock (AVTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Avalo Therapeutics, Inc. - Common Stock stock?
Investing in Avalo Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AVTX chart and related analysis on metatrader.com as part of your research.